Arthritis drug to be trialled as Covid treatment in UK care homes
by Sarah Boseley Health editor from Science | The Guardian on (#58N8E)
Adalimumab could counter hyper-inflammation seen in severe coronavirus cases
A commonly used arthritis drug is to be trialled with care home residents who have Covid, after it was observed that those taking it for their joint pains were less likely to end up in hospital with the virus.
Older people in care homes, who often have some degree of dementia, tend not to do well in hospital, where they become more confused and may pick up infections. The trial will break new ground by giving the drug to people at care homes, where they can be supervised and monitored afterwards by doctors and nurses.
Continue reading...